Evidence map›Paper›PMID 38011007›Full record

ArticleJournal of cellular and molecular medicine2024

Exploring NK-Cell molecules that impact the immune response and microenvironment in head and neck squamous cell carcinoma.

Peng Shao, Wei-Wei Hu, Xin-Lian Shi, Ming-Yang Shu, Dong-Ya Li, Tingting Zhou, Qi-Tao Zhao

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Peng ShaoDepartment of Stomatology, Huai 'an Second People's Hospital and The Affiliated Huai an Hospital of Xuzhou Medical University, Huai 'an, Jiangsu, China.
Wei-Wei HuDepartment of Stomatology, Huai 'an Second People's Hospital and The Affiliated Huai an Hospital of Xuzhou Medical University, Huai 'an, Jiangsu, China.
Xin-Lian ShiDepartment of Stomatology, Huai 'an Second People's Hospital and The Affiliated Huai an Hospital of Xuzhou Medical University, Huai 'an, Jiangsu, China.
Ming-Yang ShuDepartment of Stomatology, Huai 'an Second People's Hospital and The Affiliated Huai an Hospital of Xuzhou Medical University, Huai 'an, Jiangsu, China.
Dong-Ya LiDepartment of Stomatology, Huai 'an Second People's Hospital and The Affiliated Huai an Hospital of Xuzhou Medical University, Huai 'an, Jiangsu, China.
Tingting ZhouDepartment of Stomatology, Huai 'an Second People's Hospital and The Affiliated Huai an Hospital of Xuzhou Medical University, Huai 'an, Jiangsu, China.
Qi-Tao ZhaoDepartment of Stomatology, Huai 'an Second People's Hospital and The Affiliated Huai an Hospital of Xuzhou Medical University, Huai 'an, Jiangsu, China.ORCID 0009-0009-2786-4443
Xuzhou Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

NK cells play a role in various cancers, but their role in head and neck squamous cell carcinoma (HNSCC) still needs to be explored. All public data are obtained from the Cancer Genome Atlas Program (TCGA) database. All analysis was performed using specific packages in R software. In our study, we quantified the immune microenvironment of HNSCC through multiple algorithms. Next, we identified NK cell-associated genes by quantifying NK cells, including SSNA1, TRIR, PAXX, DPP7, WDR34, EZR, PHLDA1 and ELOVL1. Then, we explored the single-cell expression pattern of these genes in the HNSCC microenvironment. Univariate Cox regression analysis indicated that the EZR, PHLDA1 and ELOVL1 were related to the prognosis of HNSCC patients. Following this, we selected EZR for further analysis. Our results showed that the patients with high EZR expression might have a poor prognosis and worse clinical features. Biological enrichment analysis showed that EZR is associated with many oncogenic pathways and a higher tumour stemness index. Meanwhile, we found that EZR can remodel the immune microenvironment of HNSCC. Moreover, we noticed that EZR could affect the immunotherapy and specific drug sensitivity, making it an underlying clinical target. In summary, our results can improve the understanding of NK cell in HNSCC. Meanwhile, we identified EZR as the underlying clinical target of HNSCC.

Indexed as

CarcinomaHead and Neck NeoplasmsCarrier ProteinsHumansImmunityKiller Cells, NaturalSquamous Cell Carcinoma of Head and NeckTumor MicroenvironmentCarrier ProteinsWDR34 protein, humanHNSCCimmune microenvironmentimmunotherapyNK cellprognosis

Identifiers

PMID38011007
PMCPMC10826436
OpenAlexW4389070556

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.